Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Determine the Safety and Efficacy of AMG 827 in Subjects with Inadequately Controlled Asthma
2010-019543-19Phase 2Completed
- Sponsor
- Amgen
- Start
- Aug 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing AMG 827 with Placebo (2 arms). Primary endpoint: Change in ACQ composite scores from baseline to week 12. Started Aug 2010; status: completed.
02
Drugs
brodalumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-019543-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019543-19.